BMAL1 and cancer: Some HIFs, such as HIF1A, ARNT, EPAS1, and HIF3A, were linked with unfavorable outcomes for pan-cancer, while two HIFs including ARNTL and ARNT2 were associated with favorable outcomes in pan-cancer (Figure 1).